Sarah Major

549 total citations
13 papers, 308 citations indexed

About

Sarah Major is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Sarah Major has authored 13 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Sarah Major's work include Multiple Myeloma Research and Treatments (7 papers), Cancer Mechanisms and Therapy (2 papers) and Protein Degradation and Inhibitors (2 papers). Sarah Major is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Cancer Mechanisms and Therapy (2 papers) and Protein Degradation and Inhibitors (2 papers). Sarah Major collaborates with scholars based in United States, United Kingdom and Tanzania. Sarah Major's co-authors include B J Trinnaman, Anthony I. Magee, Stephen A. Martin, Zsolt Zsoldos, Yang Liu, A. Peter Johnson, Howard Y. Ando, James Law, Anikó Simon and T M Chiang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical Journal.

In The Last Decade

Sarah Major

11 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Major United States 6 145 102 83 41 35 13 308
Zachariah H. Foda United States 7 275 1.9× 39 0.4× 26 0.3× 32 0.8× 6 0.2× 9 400
Xi Jiang China 9 240 1.7× 85 0.8× 28 0.3× 17 0.4× 5 0.1× 20 317
Yu-Wen Liu Taiwan 9 231 1.6× 48 0.5× 61 0.7× 29 0.7× 16 0.5× 9 398
Yihong Yu China 9 284 2.0× 81 0.8× 9 0.1× 28 0.7× 22 0.6× 15 453
Sarah A. Dugger United States 5 199 1.4× 54 0.5× 14 0.2× 10 0.2× 38 1.1× 5 349
S Pirro Italy 9 317 2.2× 43 0.4× 9 0.1× 14 0.3× 15 0.4× 13 478
Jialin Shang China 7 225 1.6× 46 0.5× 16 0.2× 24 0.6× 3 0.1× 12 397
Samira Jaeger Germany 9 237 1.6× 77 0.8× 5 0.1× 20 0.5× 16 0.5× 17 330
Eran Agmon United States 8 285 2.0× 10 0.1× 18 0.2× 22 0.5× 38 1.1× 23 521
Yubo Fan United States 6 206 1.4× 29 0.3× 5 0.1× 13 0.3× 22 0.6× 9 309

Countries citing papers authored by Sarah Major

Since Specialization
Citations

This map shows the geographic impact of Sarah Major's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Major with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Major more than expected).

Fields of papers citing papers by Sarah Major

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Major. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Major. The network helps show where Sarah Major may publish in the future.

Co-authorship network of co-authors of Sarah Major

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Major. A scholar is included among the top collaborators of Sarah Major based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Major. Sarah Major is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Cooperrider, Jennifer H., Sarah Major, Eric Kruse, et al.. (2023). Longitudinal changes in echocardiographic variables and endothelial function to predict cardiovascular toxicities in patients with multiple myeloma receiving carfilzomib.. Journal of Clinical Oncology. 41(16_suppl). e20012–e20012.
2.
3.
4.
Major, Ajay, Jacalyn Rosenblatt, David Avigan, et al.. (2021). A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma. Blood. 138(Supplement 1). 2759–2759. 2 indexed citations
5.
Derman, Benjamin A., Jeffrey A. Zonder, Ankit Kansagra, et al.. (2021). Interim analysis of a phase 2 minimal residual disease (MRD)-adaptive trial of elotuzumab, carfilzomib, lenalidomide, and dexamethasone (Elo-KRd) for newly diagnosed multiple myeloma (MM).. Journal of Clinical Oncology. 39(15_suppl). 8011–8011. 3 indexed citations
6.
Gleason, Christine A., et al.. (2020). Impact of an Oncology Clinical Pharmacist Specialist in an Outpatient Multiple Myeloma Clinic. Clinical Lymphoma Myeloma & Leukemia. 20(9). e543–e546. 9 indexed citations
7.
Jasielec, Jagoda, Jeff Zonder, Benjamin A. Derman, et al.. (2020). Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study. Blood. 136(Supplement 1). 50–50. 4 indexed citations
8.
9.
Law, James, Zsolt Zsoldos, Anikó Simon, et al.. (2009). Route Designer: A Retrosynthetic Analysis Tool Utilizing Automated Retrosynthetic Rule Generation. Journal of Chemical Information and Modeling. 49(3). 593–602. 144 indexed citations
10.
Major, Sarah & Jane Endicott. (2004). Structural biology of cell-cycle proteins. 3(4). 136–142. 2 indexed citations
11.
Trinnaman, B J, et al.. (2002). Molecular interactions between desmosomal cadherins. Biochemical Journal. 362(2). 317–317. 95 indexed citations
12.
Hartley, William R., et al.. (1998). Gonadal development in Japanese medaka (Oryzias latipes) exposed to 17 β-estradiol. Marine Environmental Research. 46(1-5). 145–148. 20 indexed citations
13.
Major, Sarah, et al.. (1996). Upregulation of nitric oxide synthase in cultured human keratinocytes after ultraviolet B and bradykinin. Photodermatology Photoimmunology & Photomedicine. 12(2). 57–65. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zachariah H. Foda Breakdown of academic impact, for papers by Xi Jiang Breakdown of academic impact, for papers by Yu-Wen Liu Breakdown of academic impact, for papers by Yihong Yu Breakdown of academic impact, for papers by Sarah A. Dugger Breakdown of academic impact, for papers by S Pirro Breakdown of academic impact, for papers by Jialin Shang Breakdown of academic impact, for papers by Samira Jaeger Breakdown of academic impact, for papers by Eran Agmon Breakdown of academic impact, for papers by Yubo Fan
Rankless by CCL
2026